Menu
The new sharewise is here Clearer, faster, with a light and a dark view — and everything you already know. Try it now
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

Kala Pharmaceuticals Inc. sell StockNews.com

Start price
€4.78
20.07.25 / 50%
Target price
-
20.07.26
Performance (%)
-98.69%
End price
-
21.07.26
Summary
This prediction is currently being closed. The SELL prediction by StockNews_com for Kala Pharmaceuticals Inc. is performing very well with a performance of -98.69%. StockNews_com has 50% into this prediction
Performance without dividends (%)
Name 1w 1m 1y
Kala Pharmaceuticals Inc. - - -
iShares Core DAX® 0,18 % 5,07 % 8,98 %
iShares Nasdaq 100 -0,77 % -2,08 % 26,44 %
iShares Nikkei 225® 0,73 % -3,35 % 47,89 %
iShares S&P 500 -0,17 % 0,90 % 22,97 %

Comments by StockNews_com for this prediction

In the thread Kala Pharmaceuticals diskutieren

KALA BIO, Inc. (NASDAQ: KALA) was downgraded by analysts at Wall Street Zen from a "hold" rating to a "sell" rating.
Ratings data for KALA provided by MarketBeat

In the thread Trading Kala Pharmaceuticals Inc.
Prediction Sell
Perf. (%) -98.69%
Target price
Change
Ends at 20.07.26

Die von StockNews_com gewählte maximale Laufzeit wurde überschritten